Ligand Pharmaceuticals, Inc. (LGND)
237.73
+0.73
(+0.31%)
USD |
NASDAQ |
Jun 08, 16:00
237.73
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals EPS Diluted (Quarterly) : -0.6712 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Organon & Co. | 0.5554 |
| Johnson & Johnson | 2.141 |
| Merck & Co., Inc. | -1.715 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.34M |
| Revenue (Quarterly) | 51.72M |
| Total Expenses (Quarterly) | 65.07M |
| Enterprise Value | 4.419B |
| Gross Profit Margin (Quarterly) | 78.02% |
| Profit Margin (Quarterly) | -25.80% |
| Earnings Yield | 3.10% |
| Operating Earnings Yield | 2.09% |
| Normalized Earnings Yield | 2.648 |